As earnings reports continue to roll in, investors may be taking a closer look at companies that they own. Staying on top of the most recent releases may help investors figure out if the company is well-positioned for future success. Taking a look at some earnings projections, we note that the current quarter EPS consensus estimate for Aurora Cannabis Inc. (ASX:ACB) is -0.02. This EPS estimate consists of 2 sell-side analysts taken into consideration by Zacks Research. For the last reporting period, the company reported a quarterly EPS of -0.04. Sell-side analysts often provide their best researched estimates for what the company will report. These estimates carry a lot of weight on Wall Street and the investing community. When a company reports actual earnings results, the surprise factor may cause the stock price to fluctuate more than normal. Investors will often pay added attention to a company that has surpassed expectations by a wide margin.
Trying to predict the day to day short-term movements of the stock market can be nearly impossible. Stocks have the tendency to make sudden moves on even the slightest bit of news or for apparently no reason at all. The daily trader may be looking to capitalize on swings or momentum, but the long-term investor may be searching for stability and consistency over a sustained period of time. During trading sessions, stock movements can seem like a popularity contest from time to time. Even after meticulous study, there may be no logical reason for a particular stock move. Riding out the waves of uncertainty may not be easy, but having a full-proof plan for when markets turn bad might be a great help to investors for long-term portfolio health.
Wall Street analysts often give buy/sell/hold ratings for the companies that they track. Investors have the